2017
ACIST Medical Systems Announces Approval and Launch of Next-Generation FFR System
Read more
2017
ACIST Launches Direct Sales of its CVi Contrast Delivery System in Japan
Read more
2017
Impact of Post-Intervention Fractional Flow Reserve Measurement on Acute PCI Outcomes Investigated in Large Independent Registry
Read more
2017
Head-to-Head Study Validates Consistent Performance of Microcatheter FFR
Read more
2017
ACIST Japan Launches ACIST HDi® High Definition IVUS
Read more
2017
Enrollment Complete for ACIST-FFR Multi-Center Study
Read more
2016
ACIST Inc., Announces ACIST Japan Inc., Will Take Over Distribution of CVi Contrast Delivery Injector in Japan
View press release
2016
Junichi Osawa appointed to lead ACIST’s injector business in Japan together with valued partner DVx Inc.
2015
ACIST Japan facility opens.
2007
ACIST Japan, K.K is established.
2005
Launches the ACIST CVI® Contrast Delivery System, combining the capabilities of the CMS and Voyager® into one integrated system.
2004
One thousand ACIST systems are being used in more than 30 countries worldwide.
2002
ACIST partners with DVx Inc. to sell ACIST products in Japan.
1998
Renamed ACIST (Automated Contrast Injection System Technology) Medical Systems to better reflect the company’s focus.
1997
Licenses five-year marketing rights to New Jersey-based Bracco Diagnostics Inc., which has a nationwide distribution network.
1997
Receives FDA clearance to market the CL100H system, the first injection system for diagnostic and interventional cardiology.
1995
Incorporates as Invasatec.
1991
Company is founded by Dr. Robert (Bob) F. Wilson, Professor of Medicine and Director of the Interventional Cardiology Program at the University of Minnesota.
